Nigel H. Greig
27Patents
11h-index
39Co-inventors
75Inventor score
Filing activity: Aug 21, 1987 → Nov 9, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7056734B1 | Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof | Chemistry; Metallurgy | 40 | Expired |
| US7576050B2 | GLP-1 exendin-4 peptide analogs and uses thereof | Human Necessities | 36 | Expired |
| US5171750A | Substituted phenserines as specific inhibitors of acetylcholinesterase | Chemistry; Metallurgy | 33 | Expired |
| US8853160B2 | GLP-1, exendin-4, peptide analogs and uses thereof | Human Necessities | 21 | Active |
| US7973057B2 | Thalidomide analogs | Chemistry; Metallurgy | 21 | Active |
| US8278272B2 | GLP-1, exendin-4, peptide analogs and uses thereof | Human Necessities | 17 | Active |
| US6683105B2 | Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias | Chemistry; Metallurgy | 16 | Expired |
| US5409948A | Method for treating cognitive disorders with phenserine | Human Necessities | 14 | Expired |
| US6410747B1 | Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias | Chemistry; Metallurgy | 13 | Expired |
| US7153882B2 | Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof | Chemistry; Metallurgy | 13 | Expired |
| US8691864B2 | Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US8258172B2 | Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof | Chemistry; Metallurgy | 9 | Active |
| US7786162B2 | Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof | Chemistry; Metallurgy | 9 | Active |
| US5998460A | Phenylcarbamates of (-)-eseroline, (-)-N1-noreseroline and (-)-N1-benzylnoreseroline: selective inhibitors of acetyl and butyrylcholinesterase, pharmaceutical compositions and method of use thereof | Chemistry; Metallurgy | 8 | Expired |
| US8927725B2 | Thio compounds | Emerging Cross-Sectional Technologies | 6 | Active |
| US5378723A | Carbamate analogs of thiaphysovenine and method for inhibiting cholinesterases | Human Necessities | 6 | Expired |
| US10836721B2 | Thalidomide analogs and methods of use | Chemistry; Metallurgy | 1 | Active |
| US4835182A | Enhancing drug delivery to the brain | Human Necessities | 1 | Expired |
| US11273130B2 | Methods of delivering a neuroprotective polypeptide to the central nervous system | Human Necessities | 0 | Active |
| US8853253B2 | Thalidomide analogs | Electricity | 0 | Active |
| US10730835B2 | Thalidomide analogs and methods of use | Chemistry; Metallurgy | 0 | Active |
| US10220028B2 | Thio compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US9623020B2 | Thio compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US8546430B2 | Thalidomide analogs | Chemistry; Metallurgy | 0 | Active |
| US11771657B2 | Methods of delivering a neuroprotective polypeptide to the central nervous system | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.